Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Digital System Receives European Mammographic Certification

By HospiMedica International staff writers
Posted on 14 Apr 2011
A European Certification for a digital mammography system ensures users that the digital mammography system meets or exceeds rigorous European image quality and dose standards.

Hologic, Inc. More...
(Bedford, MA, USA), a developer, manufacturer, and supplier of diagnostics products, medical imaging systems, and surgical products dedicated to serving the healthcare needs of women, reported that its Selenia Dimensions digital mammography system in two-dimensional (2D) mode has been awarded EUREF type test certification by the European Reference Organization Council for Quality Assured Breast Screening and Diagnostic Services (EUREF; Nijmegen, The Netherlands). Only three products have received EUREF approval to date, of which two are Hologic systems--namely, the Selenia digital mammography system and now Selenia Dimensions, a breast cancer screening and diagnosis technology.

The mission of the nonprofit EUREF council is to raise standards by bringing together, at the European level, the best examples of quality control in mammography screening from regional and national breast cancer screening programs. EUREF mammographic type test certification ensures hospitals and imaging centers that the Hologic Selenia Dimensions system in 2D mode has passed a rigorous series of physics and clinical tests demonstrating the system meets the image quality, radiation exposure, and stability standards set by EUREF for screening and diagnostic mammography equipment.

"Hologic has a reputation for following rigorous manufacturing standards and processes including International Organization for Standardization registration and CE mark certification for our Selenia and Selenia Dimensions digital mammography systems,” said David Harding, senior vice president and general manager, International at Hologic. For some time we have been offering our Selenia Dimensions system in 2D and/or 3D mode in our international markets. On February 11, 2011, the US Food and Drug Administration [FDA] approved using the Selenia Dimensions system in either or both modes in the US. The quality and stability of the system certified by EUREF combined with the recent 3D approval by the FDA sets the Selenia Dimensions breast cancer screening and diagnostic platform in a class of its own.”

Related Links:
Hologic
European Reference Organization



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
X-Ray Meter
Cobia SENSE
Exam Table
PF400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.